(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO RGD:1614369 6480464 2 more ... CTD PMID:18579281 1,2-dimethylhydrazine decreases expression ISO RGD:1614369 6480464 1, 2-Dimethylhydrazine results in decreased expression of FAM134B mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1614369 6480464 Ethinyl Estradiol affects the expression of RETREG1 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1601869 6480464 Estradiol results in increased expression of RETREG1 mRNA CTD PMID:23019147 , PMID:24758408 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:1601869 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RETREG1 mRNA more ... CTD PMID:17404688 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RETREG1 mRNA CTD PMID:18796159 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1614369 6480464 Tetrachlorodibenzodioxin results in increased expression of RETREG1 mRNA CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614369 6480464 Tetrachlorodibenzodioxin affects the expression of RETREG1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614369 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RETREG1 gene] CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614369 6480464 Tetrachlorodibenzodioxin results in decreased expression of RETREG1 mRNA CTD PMID:19770486 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1601869 6480464 2 more ... CTD PMID:26705709 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1601869 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1614369 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of RETREG1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO RGD:1601869 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of RETREG1 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:1614369 6480464 Fenretinide results in increased expression of RETREG1 mRNA CTD PMID:28973697 aflatoxin B1 increases methylation ISO RGD:1601869 6480464 Aflatoxin B1 results in increased methylation of FAM134B intron, Aflatoxin B1 results in increased methylation of RETREG1 gene CTD PMID:27153756 , PMID:30157460 aldehydo-D-glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 aldrin decreases expression ISO RGD:1614369 6480464 Aldrin results in decreased expression of RETREG1 mRNA CTD PMID:18579281 antirheumatic drug decreases expression ISO RGD:1601869 6480464 Antirheumatic Agents results in decreased expression of RETREG1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1601869 6480464 aristolochic acid I results in increased expression of RETREG1 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO RGD:1614369 6480464 Benzo(a)pyrene results in decreased expression of RETREG1 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1601869 6480464 Benzo(a)pyrene results in decreased expression of RETREG1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1601869 6480464 Benzo(a)pyrene affects the methylation of FAM134B promoter CTD PMID:27901495 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1614369 6480464 bisphenol A results in increased expression of RETREG1 mRNA CTD PMID:32156529 , PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RETREG1 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RETREG1 mRNA CTD PMID:33296240 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RETREG1 mRNA CTD PMID:25181051 buspirone increases expression EXP 6480464 Buspirone results in increased expression of RETREG1 mRNA CTD PMID:24136188 carbamazepine affects expression ISO RGD:1601869 6480464 Carbamazepine affects the expression of RETREG1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1614369 6480464 Nanotubes, Carbon results in increased expression of RETREG1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1614369 6480464 Nanotubes, Carbon results in decreased expression of RETREG1 mRNA CTD PMID:25620056 chloroethene decreases expression ISO RGD:1614369 6480464 Vinyl Chloride results in decreased expression of RETREG1 mRNA CTD PMID:18579281 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 cisplatin increases expression ISO RGD:1601869 6480464 Cisplatin results in increased expression of RETREG1 mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions ISO RGD:1601869 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RETREG1 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1601869 6480464 cobaltous chloride results in increased expression of RETREG1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1614369 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1614369 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1614369 6480464 Copper Sulfate results in decreased expression of RETREG1 mRNA CTD PMID:18579281 cyclosporin A increases expression ISO RGD:1601869 6480464 Cyclosporine results in increased expression of RETREG1 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1614369 6480464 Cyclosporine results in decreased expression of RETREG1 mRNA CTD PMID:19770486 D-glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of RETREG1 mRNA CTD PMID:32679240 dexamethasone increases expression ISO RGD:1601869 6480464 Dexamethasone results in increased expression of RETREG1 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1601869 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 diuron decreases expression EXP 6480464 Diuron results in decreased expression of RETREG1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1601869 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1601869 6480464 Doxorubicin results in decreased expression of RETREG1 mRNA CTD PMID:29803840 fenthion increases expression ISO RGD:1614369 6480464 Fenthion results in increased expression of RETREG1 mRNA CTD PMID:34813904 furan increases expression EXP 6480464 furan results in increased expression of RETREG1 mRNA CTD PMID:26194646 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RETREG1 mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RETREG1 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of RETREG1 mRNA CTD PMID:24136188 glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of RETREG1 mRNA CTD PMID:20621112 indometacin multiple interactions ISO RGD:1601869 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 isotretinoin decreases expression ISO RGD:1601869 6480464 Isotretinoin results in decreased expression of RETREG1 mRNA CTD PMID:20436886 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of RETREG1 mRNA CTD PMID:22641619 lead(0) affects expression ISO RGD:1601869 6480464 Lead affects the expression of RETREG1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1601869 6480464 Lead affects the expression of RETREG1 mRNA CTD PMID:28903495 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of RETREG1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1601869 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RETREG1 mRNA CTD PMID:35811015 menadione affects expression ISO RGD:1601869 6480464 Vitamin K 3 affects the expression of RETREG1 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RGD:1601869 6480464 mercuric bromide results in increased expression of RETREG1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1601869 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FAM134B mRNA CTD PMID:30467583 methylmercury chloride decreases expression ISO RGD:1601869 6480464 methylmercuric chloride results in decreased expression of RETREG1 mRNA CTD PMID:28001369 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of RETREG1 mRNA CTD PMID:24136188 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of RETREG1 mRNA, Nevirapine results in increased expression of RETREG1 mRNA CTD PMID:23947594 nickel sulfate increases expression ISO RGD:1601869 6480464 nickel sulfate results in increased expression of RETREG1 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:1601869 6480464 methyleugenol results in decreased expression of RETREG1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RETREG1 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1614369 6480464 Acetaminophen affects the expression of RETREG1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1601869 6480464 Acetaminophen results in decreased expression of RETREG1 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of RETREG1 mRNA CTD PMID:32680482 parathion increases expression ISO RGD:1614369 6480464 Parathion results in increased expression of RETREG1 mRNA CTD PMID:34813904 phenylmercury acetate increases expression ISO RGD:1601869 6480464 Phenylmercuric Acetate results in increased expression of RETREG1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1601869 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1601869 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RETREG1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1614369 6480464 pirinixic acid results in increased expression of RETREG1 mRNA CTD PMID:17426115 potassium chromate increases expression ISO RGD:1601869 6480464 potassium chromate(VI) results in increased expression of RETREG1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1614369 6480464 Pregnenolone Carbonitrile results in increased expression of RETREG1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1601869 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RETREG1 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:17404688 , PMID:20660070 propanal increases expression ISO RGD:1601869 6480464 propionaldehyde results in increased expression of RETREG1 mRNA CTD PMID:26079696 propiconazole decreases expression ISO RGD:1614369 6480464 propiconazole results in decreased expression of RETREG1 mRNA CTD PMID:21278054 raloxifene multiple interactions ISO RGD:1601869 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of RETREG1 mRNA CTD PMID:19059307 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1601869 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RETREG1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1601869 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1601869 6480464 Silicon Dioxide analog results in decreased expression of RETREG1 mRNA CTD PMID:25895662 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RETREG1 mRNA CTD PMID:25993096 tamoxifen multiple interactions ISO RGD:1601869 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of RETREG1 mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:1614369 6480464 Tamoxifen affects the expression of RETREG1 mRNA CTD PMID:17555576 , PMID:20937368 temozolomide decreases expression ISO RGD:1601869 6480464 Temozolomide results in decreased expression of RETREG1 mRNA CTD PMID:31758290 tetrachloroethene increases expression ISO RGD:1614369 6480464 Tetrachloroethylene results in increased expression of RETREG1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1614369 6480464 Carbon Tetrachloride results in increased expression of RETREG1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RETREG1 mRNA CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:1614369 6480464 Carbon Tetrachloride affects the expression of RETREG1 mRNA CTD PMID:17484886 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RETREG1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1601869 6480464 trichostatin A results in increased expression of RETREG1 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1601869 6480464 Valproic Acid affects the expression of RETREG1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1601869 6480464 Valproic Acid results in increased expression of RETREG1 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:1601869 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RETREG1 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1601869 6480464 Vitamin E results in decreased expression of RETREG1 mRNA CTD PMID:19244175 zoledronic acid increases expression ISO RGD:1601869 6480464 zoledronic acid results in increased expression of RETREG1 mRNA CTD PMID:24714768